Beyer, Susanne http://orcid.org/0000-0001-8603-6714
Wehrmann, Maya
Meister, Sarah
Kolben, Theresa M.
Trillsch, Fabian
Burges, Alexander
Czogalla, Bastian
Schmoeckel, Elisa
Mahner, Sven
Jeschke, Udo
Kolben, Thomas
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
Article History
Received: 28 November 2020
Accepted: 9 February 2022
First Online: 4 April 2022
Declarations
:
: T. Kolben has a relative employed at Roche and holds stock of Roche. T.M. Kolben is employed at Roche and holds stock of Roche. F. Trillsch declares Research support, advisory board, honoraria and travel expenses from AstraZeneca, Clovis, Medac, PharmaMar, Roche, Tesaro. S. Mahner has received Research support, advisory board, honoraria and travel expenses from AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Medac, MSD, Novartis, Olympus, PharmaMar, Roche, Sensor Kinesis, Teva, Tesaro. All other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The study was approved by the ethics committee of the Ludwig-Maximilians University Munich (reference number: 048-08; 2008). Patient data were anonymized.
: Not applicable as all data are anonymized.
: Not applicable as all data are anonymized.